These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9354689

  • 21. Storage iron kinetics. VII. A biologic model for reticuloendothelial iron transport.
    Fillet G, Cook JD, Finch CA.
    J Clin Invest; 1974 Jun; 53(6):1527-33. PubMed ID: 4830220
    [Abstract] [Full Text] [Related]

  • 22. The mechanism of endotoxin-induced hypoferraemia.
    Torrance JD, Charlton RW, Simon MO, Lynch SR, Bothwell TH.
    Scand J Haematol; 1978 Nov; 21(5):403-10. PubMed ID: 366729
    [Abstract] [Full Text] [Related]

  • 23. Mobilisation of iron from peritoneal rat macrophages by desferrioxamine.
    Kleber EE, Torrance JD, Bothwell TH, Simon MO, Charlton RW.
    Scand J Haematol; 1981 Sep; 27(3):209-18. PubMed ID: 7313547
    [Abstract] [Full Text] [Related]

  • 24. Factors involved in the regulation of iron transport through reticuloendothelial cells.
    Siegenberg D, Baynes RD, Bothwell TH, MacFarlane BJ, Lamparelli RD.
    Proc Soc Exp Biol Med; 1990 Jan; 193(1):65-72. PubMed ID: 2294524
    [Abstract] [Full Text] [Related]

  • 25. The effect of transferrin saturation on internal iron exchange.
    Bergamaschi G, Eng MJ, Huebers HA, Finch CA.
    Proc Soc Exp Biol Med; 1986 Oct; 183(1):66-73. PubMed ID: 3749034
    [Abstract] [Full Text] [Related]

  • 26. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1).
    Kontoghiorghes GJ, Pattichi K, Hadjigavriel M, Kolnagou A.
    Transfus Sci; 2000 Dec; 23(3):211-23. PubMed ID: 11099897
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of iron-chelating agents in cultured heart muscle cells. Identification of a potential drug for chelation therapy.
    Sciortino CV, Byers BR, Cox P.
    J Lab Clin Med; 1980 Dec; 96(6):1081-5. PubMed ID: 7430764
    [Abstract] [Full Text] [Related]

  • 28. Storage iron exchange in the rat as affected by deferoxamine.
    Kim BK, Huebers H, Pippard MJ, Finch CA.
    J Lab Clin Med; 1985 Apr; 105(4):440-8. PubMed ID: 3920336
    [Abstract] [Full Text] [Related]

  • 29. Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
    Rahman YE, Cerny EA, Lau EH, Carnes BA.
    Blood; 1983 Jul; 62(1):209-13. PubMed ID: 6407548
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness of oral iron chelators assayed in the rat.
    Kim BK, Huebers HA, Finch CA.
    Am J Hematol; 1987 Mar; 24(3):277-84. PubMed ID: 3826055
    [Abstract] [Full Text] [Related]

  • 31. Subchronic oral administration of gossypol-acetic acid (GAA) alters the distribution and utilization of radioiron in male rats.
    Reynolds JM, Tone JN.
    Drug Chem Toxicol; 1988 Jun; 11(2):135-50. PubMed ID: 3402348
    [Abstract] [Full Text] [Related]

  • 32. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ, Sheppard L, Hoffbrand AV, Charalambous J, Tikerpae J, Pippard MJ.
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [Abstract] [Full Text] [Related]

  • 33. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
    Link G, Pinson A, Hershko C.
    Blood; 1994 May 01; 83(9):2692-7. PubMed ID: 8167347
    [Abstract] [Full Text] [Related]

  • 34. The effect of acute inflammation on iron metabolism in rats.
    Uchida T, Igarashi T, Suzuki T, Kokubun K, Matsuda S, Kariyone S.
    Tohoku J Exp Med; 1983 Mar 01; 139(3):293-8. PubMed ID: 6857649
    [Abstract] [Full Text] [Related]

  • 35. Biliary excretion of plasma non-transferrin-bound iron in rats: pathogenetic importance in iron-overload disorders.
    Brissot P, Zanninelli G, Guyader D, Zeind J, Gollan J.
    Am J Physiol; 1994 Jul 01; 267(1 Pt 1):G135-42. PubMed ID: 8048526
    [Abstract] [Full Text] [Related]

  • 36. Biliary iron excretion in rats following treatment with analogs of pyridoxal isonicotinoyl hydrazone.
    Bláha K, Cikrt M, Nerudová J, Ponka HF.
    Blood; 1998 Jun 01; 91(11):4368-72. PubMed ID: 9596686
    [Abstract] [Full Text] [Related]

  • 37. In vivo evidence for the functional heterogeneity of transferrin-bound iron. III. Studies of transferrin at high and low iron saturation.
    Brown EB, Okada S, Awai M, Chipman B.
    J Lab Clin Med; 1975 Oct 01; 86(4):576-85. PubMed ID: 1176811
    [Abstract] [Full Text] [Related]

  • 38. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
    Hershko C, Avramovici-Grisaru S, Link G, Gelfand L, Sarel S.
    J Lab Clin Med; 1981 Jul 01; 98(1):99-108. PubMed ID: 7252329
    [Abstract] [Full Text] [Related]

  • 39. Phenolic ethylenediamine derivatives: a study of orally effective iron chelators.
    Hershko C, Grady RW, Link G.
    J Lab Clin Med; 1984 Mar 01; 103(3):337-46. PubMed ID: 6699459
    [Abstract] [Full Text] [Related]

  • 40. The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogue.
    Yokel RA, Fredenburg AM, Durbin PW, Xu J, Rayens MK, Raymond KN.
    J Pharm Sci; 2000 Apr 01; 89(4):545-55. PubMed ID: 10737916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.